The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines

Pituitary

Volumn 18, Issue 4, 2015, Pages 568-574

  Lois, K ^a   Bukowczan, J ^a   Perros, P ^a   Jones, S ^b   Gunn, M ^a   James, R A ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NORTH TEES AND HARTLEPOOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acromegaly; Adenoma; Colonoscopy; Colorectal cancer; Guidelines; Screening

Indexed keywords

AMLODIPINE; ANGIOPEPTIN; ATENOLOL; CABERGOLINE; CANDESARTAN; FERROUS FUMARATE; GONADOTROPIN; GROWTH HORMONE; HEMOGLOBIN; LANSOPRAZOLE; PAROXETINE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ABDOMINAL DISCOMFORT; ACROMEGALY; ADULT; BODY MASS; CASE REPORT; CAUSE OF DEATH; COARSE FACE; COLON TUMOR; COLONOSCOPY; COLORECTAL CARCINOMA; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DYSPNEA; ECHOGRAPHY; ELECTRON THERAPY; FEMALE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOPHYSIS ADENOMA; IMPAIRED GLUCOSE TOLERANCE; IRON DEFICIENCY ANEMIA; JEJUNOSTOMY; LAPAROTOMY; LIVER METASTASIS; LUNG METASTASIS; MEDICAL HISTORY; MENSTRUAL CYCLE; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; SLEEP DISORDERED BREATHING; SMALL INTESTINE OBSTRUCTION; STEREOTAXIC SURGERY; TRANSSPHENOIDAL SURGERY; WEIGHT REDUCTION; ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; COMPLICATION; EARLY DIAGNOSIS; PRECANCEROUS CONDITIONS;

ACROMEGALY; ADENOCARCINOMA; ADENOMA; ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS;

EID: 84932195304     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-014-0586-5     Document Type: Review

References (51)

1. Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. Q J Med 39(153):1–16
2. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol (Oxf) 12(1):71–79
3. Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377–382
4. Pines A, Rozen P, Ron E, Gilat T (1985) Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 80(4):266–269
5. Nabarro JD (1987) Acromegaly. Clin. Endocrinol (Oxf) 26(4):481–512
6. Ezzat S, Melmed S (1991) Clinical review 18: are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 72:245–249
7. Muto T, Bussey HJ, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36:2251–2270
8. Simmons JG, Pucilowska JB, Lund PK (1999) Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors. Am J Physiol 276:G817–G827
9. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC (1994) Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58:452–459
10. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N (1992) Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 65:341–346
11. Cats A, Dullaart RP, Kleibeuker JH, Kuipers F, Sluiter WJ, Hardonk MJ, de Vries EG (1996) Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56:523–526
12. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC (1990) Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 32(1):65–71
13. Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P, Bove A, Iodice G, Merola B, Lombardi G (1997) Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol 47(1):23–28
14. Delhougne B, Deneux C, Abs R, Chanson P, Fierens H, Laurent-Puig P, Duysburgh I, Stevenaert A, Tabarin A, Delwaide J, Schaison G, Belaïche J, Beckers A (1995) The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. J Clin Endocrinol Metab 80:3223–3226
15. Ezzat S, Strom C, Melmed S (1991) Colon polyps in acromegaly. Ann Intern Med 114:754–755
16. Ituarte EM, Petrini J, Hershman JM (1984) Acromegaly and colon cancer. Ann Intern Med 101:627–628
17. Klein I, Parveen G, Gavaler JS, Vanthiel DH (1982) Colonic polyps in patients with acromegaly. Ann Intern Med 97:27–30
18. Terzolo M, Tappero G, Borretta G, Asnaghi G, Pia A, Reimondo G, Boccuzzi A, Cesario F, Rovero E, Paccotti P et al (1994) High prevalence of colonic polyps in patients with acromegaly: influence of sex and age. Arch Intern Med 154:1272–1276
19. Vasen HF, van Erpecum KJ, Roelfsema F, Raue F, Koppeschaar H, Griffioen G, van Berge Henegouwen GP (1994) Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol 131:235–237
20. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M (1995) Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 80:3395–3402
21. Melmed S, Jackson I, Kleinberg D, Klibanski A (1998) Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 83:2646–2652
22. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529
23. Turner HE, Wass JA (2000) Modern approaches to treating acromegaly. Q J Med 93:1–6
24. Klein I (1984) Acromegaly and cancer. Ann Intern Med 101:706–707
25. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J (1998) Increased incidence of neoplasia in patients with pituitary adenomas: the Pituitary Study Group. Clin Endocrinol (Oxf) 49:441–445
26. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M (1997) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol 47:17–22
27. Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G, Scillitani A, Attanasio R, Cecconi E, Daffara F, Gaia E, Martino E, Lombardi G, Angeli A, Colao A (2005) Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90:84–90
28. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr (1991) Acromegaly and gastrointestinal cancer. Cancer 68:1673–1677
29. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730–2734
30. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395–400
31. Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935–2941
32. Ladas SD, Thalassinos NC, Ioannides G, Raptis SA (1994) Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours? Clin Endocrinol 41(5):597–601
33. Renehan AG, Bhaskar P, Painter JE, O’Dwyer ST, Haboubi N, Varma J, Ball SG, Shalet SM (2000) The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3417–3424
34. Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484–3489
35. Giustina A, Chanson P, Kleinberg D, Bronstein MD, Clemmons DR, Klibanski A, van der Lely AJ, Strasburger CJ, Lamberts SW, Ho KK, Casanueva FF, Melmed S (2014) Expert consensus document: a consensus on the medical treatment of acromegaly. Nat Rev Endocrinol 10(4):243–248
36. Jenkins PJ, Frajese V, Jones AM, Camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM (2000) Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218–3221
37. Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL, Akker SA, Drake WM, Fairclough PD, Grossman AB, Jenkins PJ (2010) Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. Eur J Endocrinol 163:21–28
38. Jenkins PJ, Mills TD, Veysey MJ et al (1997) Acromegaly is associated with colonomegaly which correlates with tissue exposure to growth hormone and may be implicated in their increased risk of colorectal neoplasia. J Endocrinol 155 (suppl 2): OC22 [Abstract]
39. Veysey MJ, Thomas LA, Mallet A, Jenkins PJ, Besser GM, Wass JA, Murphy GM, Dowling RH (1999) Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut 44:675–681
40. Lee TJ, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, Nickerson C, McNally RJ, Patnick J, Rees CJ (2012) Colonoscopy quality measures: experience from the NHS bowel cancer screening programme. Gut 61:1050–1057
41. Plumb AA, Halligan S, Taylor SA, Burling D, Nickerson C, Patnick J (2013) CT colonography in the English bowel cancer screening programme: national survey of current practice. Clin Radiol 68:479–487
42. Pickhardt PJ, Hassan C, Halligan S, Marmo R (2011) Colorectal cancer: CT colonography and colonoscopy for detection: systematic review and meta-analysis. Radiology 259:393–405
43. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR (2010) British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland.: British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59: 666–689
44. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK (2011) American association of clinical endocrinologists: medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update. Endocr Pract 17:1–44
45. Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts CJ, Strasburger CJ, Waas JAH, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294–302
46. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A (1998) Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42(5):711–714
47. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150(1):1–8
48. Rabeneck L, Paszat LF, Saskin R, Stukel TA (2010) Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 105(7):1627–1632
49. Baxter NN, Warren JL, Barrett MJ, Stukel TA, Doria-Rose VP (2012) Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30(21):2664–2669
50. Oza VM, Frankel WL, Conwell DL (2013) Colorectal-cancer incidence and mortality after screening. N Engl J Med 369(24):2354–2355
51. Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ (2014) A randomized trial to increase colonoscopy screening in members of high risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-13-1085